Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2015. Start Trial.
Date Value
October 05, 2026 9.118
October 02, 2026 9.112
October 01, 2026 9.090
September 30, 2026 9.110
September 29, 2026 9.12
September 28, 2026 9.199
September 25, 2026 9.021
September 24, 2026 9.225
September 23, 2026 8.922
September 22, 2026 9.500
September 21, 2026 9.501
September 18, 2026 9.466
September 17, 2026 9.559
September 16, 2026 9.904
September 15, 2026 9.588
September 14, 2026 10.59
September 11, 2026 10.54
September 10, 2026 10.45
September 09, 2026 10.43
September 08, 2026 10.80
September 04, 2026 10.82
September 03, 2026 10.84
September 02, 2026 10.69
September 01, 2026 10.41
August 31, 2026 10.52
Date Value
August 28, 2026 9.913
August 27, 2026 9.971
August 26, 2026 10.01
August 25, 2026 10.12
August 24, 2026 10.07
August 21, 2026 10.13
August 20, 2026 10.19
August 19, 2026 10.38
August 18, 2026 9.951
August 17, 2026 9.893
August 14, 2026 9.937
August 13, 2026 9.846
August 12, 2026 10.22
August 11, 2026 10.18
August 10, 2026 10.22
August 07, 2026 10.21
August 06, 2026 9.991
August 05, 2026 9.765
August 04, 2026 9.781
August 03, 2026 9.735
July 31, 2026 9.753
July 30, 2026 10.04
July 29, 2026 10.08
July 28, 2026 10.17
July 27, 2026 10.13

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 1.762
Novo Nordisk A/S 4.903
Evaxion AS 2.756
Genmab A/S 3.856
Zealand Pharma A/S 1.014

Price to Book Value Related Metrics